ATE274574T1 - Verfahren zur abschwächung von viren - Google Patents

Verfahren zur abschwächung von viren

Info

Publication number
ATE274574T1
ATE274574T1 AT98928866T AT98928866T ATE274574T1 AT E274574 T1 ATE274574 T1 AT E274574T1 AT 98928866 T AT98928866 T AT 98928866T AT 98928866 T AT98928866 T AT 98928866T AT E274574 T1 ATE274574 T1 AT E274574T1
Authority
AT
Austria
Prior art keywords
virus
membrane receptor
receptor preparation
supernatant
suspension
Prior art date
Application number
AT98928866T
Other languages
English (en)
Inventor
Alan Barrett
Kate Ryman
Haolin Ni
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,272 external-priority patent/US6010894A/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE274574T1 publication Critical patent/ATE274574T1/de

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98928866T 1997-06-13 1998-06-08 Verfahren zur abschwächung von viren ATE274574T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/874,272 US6010894A (en) 1997-06-13 1997-06-13 Method of screening for attenuating viruses
US9098298A 1998-06-05 1998-06-05
PCT/US1998/011329 WO1998056896A1 (en) 1997-06-13 1998-06-08 Method of attenuating viruses

Publications (1)

Publication Number Publication Date
ATE274574T1 true ATE274574T1 (de) 2004-09-15

Family

ID=26782846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928866T ATE274574T1 (de) 1997-06-13 1998-06-08 Verfahren zur abschwächung von viren

Country Status (8)

Country Link
EP (1) EP0922092B1 (de)
JP (1) JP2002514088A (de)
CN (1) CN1229434A (de)
AT (1) ATE274574T1 (de)
CA (1) CA2263993A1 (de)
DE (1) DE69825847D1 (de)
IL (1) IL128382A (de)
NZ (1) NZ333990A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103289966B (zh) * 2013-07-03 2014-11-05 青岛易邦生物工程有限公司 一种猪乙型脑炎病毒弱毒株
EP3031923A1 (de) * 2014-12-11 2016-06-15 Institut Pasteur Lentivirale, vektorbasierte immunogene Zusammensetzung gegen Japanische Enzephalitis

Also Published As

Publication number Publication date
IL128382A (en) 2001-12-23
JP2002514088A (ja) 2002-05-14
NZ333990A (en) 2000-10-27
EP0922092A1 (de) 1999-06-16
CN1229434A (zh) 1999-09-22
DE69825847D1 (de) 2004-09-30
IL128382A0 (en) 2000-01-31
EP0922092A4 (de) 2001-09-19
EP0922092B1 (de) 2004-08-25
CA2263993A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
Ober et al. Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+ CD8+ memory T-helper cells in swine
DE3768833D1 (de) Verfahren zur herstellung von hcmv-glykoproteinen, antikoerper dagegen und hcmv-vakzine und dazu zu verwendende rekombinante vektoren.
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE69535018D1 (de) Papillomavirus vakzine
DK0980387T3 (da) PRRSV-antigene sites, der identificerer peptidsekvenser af PRRS-virus, til anvendelse i vacciner eller diagnostiske assays
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
DE69933433D1 (de) Virus enthaltende zusammensetzungen und methoden zur konzentration von viruspräparaten
DK375283D0 (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmader til fremstilling af kvaegvaeksthormonlignende polypeptider
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
ATA155598A (de) Neue influenzavirus-impfstoffzusammensetzung
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
FI942369A0 (fi) Hepatitis-C-virustesti
WO1993001210A3 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
CY1107431T1 (el) Σωματιδια για γoνιδιακη θεραπεια
ATE237691T1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
ATE16454T1 (de) Influenzavirus-vaccine, verfahren zu ihrer herstellung und verfahren zur vermehrung von influenzaviren.
ATE274574T1 (de) Verfahren zur abschwächung von viren
MXPA02012593A (es) Particulas de tipo virus del virus de la diarrea viral bovina.
AP2368A (en) Novel expression vectors and uses thereof.
DE69333992D1 (de) Verfahren zur herstellung eines sets von kombinatorischen polypeptidantigenen
ATE93394T1 (de) Verfahren zur herstellung und verwendung von katzenleukaemievirus-antigenen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties